Patient-Reported Clinical Characteristics in a Randomized Controlled Trial in Seasonal Allergic Rhinitis (SAR)

In a clinical trial of azelastine HCL/fluticasone propionate (AZ/FP) nasal spray (Dymista) in patients with SAR, a rhinitis questionnaire1 was used to identify patient demographic and clinical characteristics (n=831).

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 135; no. 2; p. AB219
Main Authors Bernstein, Jonathan A., MD, FAAAAI, Ruiz, Nancy, MD
Format Journal Article
LanguageEnglish
Published St. Louis Elsevier Limited 01.02.2015
Subjects
Allergies
Allergy and Immunology
Asthma
Nose
Online AccessGet full text

Cover

More Information
Summary:In a clinical trial of azelastine HCL/fluticasone propionate (AZ/FP) nasal spray (Dymista) in patients with SAR, a rhinitis questionnaire1 was used to identify patient demographic and clinical characteristics (n=831).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.12.1650